(NYSE: ELAN) Elanco Animal Health's forecast annual revenue growth rate of 3.12% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.45%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.42%.
Elanco Animal Health's revenue in 2025 is $4,439,000,000.On average, 7 Wall Street analysts forecast ELAN's revenue for 2025 to be $2,212,485,313,395, with the lowest ELAN revenue forecast at $2,198,558,963,300, and the highest ELAN revenue forecast at $2,244,068,391,919. On average, 7 Wall Street analysts forecast ELAN's revenue for 2026 to be $2,309,264,444,579, with the lowest ELAN revenue forecast at $2,290,689,218,062, and the highest ELAN revenue forecast at $2,343,871,592,733.
In 2027, ELAN is forecast to generate $2,407,665,414,872 in revenue, with the lowest revenue forecast at $2,369,441,649,589 and the highest revenue forecast at $2,439,930,566,020.